Jason Babik was appointed CEO of the company, according to an Oct. 17 news release. Founders Carl Medgaus, DMD, and Bari Medgaus will also continue with the company. Dr. Medgaus will serve as chief innovation and training officer and board chair, while Ms. Medgaus will serve as chief marketing and clinical success officer.
The company said its funding will support the acceleration of growth and commercialization.
